Update to HUD financing program supports construction of affordable housing … Morning Pointe of Greeneville earns deficiency-free health licensure survey … Lack of purpose, personal growth may precede...
Risk of Parkinson’s disease heightened in people with anxiety
Jul 22, 2024
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
3 new dementia studies of note
Oct 27, 2015
New research quantifies costs associated with dementia care compared with other diseases and offers a little good news for those with Lewy body dementia or Alzheimer’s disease.
Dementia: Detection possible 9 years before diagnosis and could lead to earlier interventions, researchers...
By
Kimberly Bonvissuto
Oct 18, 2022
Detecting signs of dementia up to nine years before diagnosis is possible and could lead to earlier interventions to reduce development of the disease and help recruit people to participate in clinical...
Dementia drug helps prevent falls in those with Parkinson’s
By
Lois A. Bowers
Jan 13, 2016
A drug commonly prescribed to treat symptoms of dementia could help prevent falls for people with Parkinson’s disease, according to new research.
More news for Thursday, June 1
May 31, 2017
Mobility aids may increase fall risk for those with dementia … Handwashing: Cool water as effective as hot for removing germs … Infection with seasonal flu may increase risk of developing Parkinson’s...
More news for Friday, June 16
Jun 15, 2017
Alzheimer’s affects twice as many people as estimated … Statins may not be used for protection against Parkinson’s disease … Liquid laundry detergent pods pose lethal risk for adults...
New law calls for creation of ‘first-ever’ national plan, council to conquer Parkinson’s disease
By
Lois A. Bowers
Jul 08, 2024
The Department of Health and Human Services will form a federal advisory council that will provide recommendations for making progress against Parkinson’s disease, as well as implement a national plan...
Anticholinergic drugs don’t raise dementia risk in those with Parkinson’s
By
Lois A. Bowers
Jan 05, 2016
Concern that anticholinergic drugs could potentially worsen cognition in those with Parkinson’s disease are unfounded, according to new research reported in the Journal of Parkinson’s Disease.
More news for Monday, Jan. 22
By
Kimberly Bonvissuto
Jan 22, 2024
Boosting CNA workforce is focus of state association campaign … Tracking conditions in older adults may help ID those at risk of cognitive impairment … Hackers stole $7.5M from HHS, leaving grant recipients...